Perinatal & Reproductive

Postpartum (Peripartum) Depression

A major depressive episode occurring during pregnancy or in the weeks following childbirth.

← Back to Conditions We Treat

Definition and Diagnosis

Postpartum depression, termed peripartum-onset depression in DSM-5-TR, is a major depressive episode with onset during pregnancy or within four weeks of delivery (though clinically the term is often used more broadly for episodes within the first year postpartum), marked by depressed mood, anhedonia, and associated symptoms affecting a new parent's functioning.

Epidemiology

Postpartum depression affects a substantial proportion of birthing parents, making it one of the most common complications of childbirth. Rates are higher among those with a history of depression, and the condition is under-recognized and under-treated in many settings due to stigma and overlap with normal postpartum adjustment.

Risk Factors

Risk factors include a personal or family history of depression or bipolar disorder, prior postpartum depression, limited social support, unplanned or unwanted pregnancy, birth complications, marital or financial stress, and a difficult infant temperament or infant health problems.

Symptoms and Subtypes

Features include persistent low mood, loss of interest or pleasure, excessive guilt (often centered on perceived inadequacy as a parent), sleep and appetite disturbance beyond what is expected postpartum, poor concentration, and, in some cases, intrusive thoughts of harm to the infant, which cause significant distress and are typically egodystonic.

Diagnosis

Diagnosis follows standard major depressive episode criteria with peripartum onset, distinguished from the much more common and milder "baby blues" by duration beyond two weeks and functional impairment. Screening tools such as the Edinburgh Postnatal Depression Scale are widely used in obstetric and primary care settings.

Treatment

Treatment includes psychotherapy, particularly CBT and interpersonal therapy, and antidepressant medication, with several SSRIs considered relatively compatible with breastfeeding. Brexanolone and zuranolone, neurosteroid-based medications approved specifically for postpartum depression, offer rapid symptom relief in some settings. Peer support and involvement of partners and family are important adjuncts.

Prognosis

With treatment, most individuals achieve full recovery, though untreated postpartum depression can persist for months and negatively affect infant bonding and development. Risk of recurrence in future pregnancies is elevated, making close monitoring in subsequent peripartum periods important.

Reference

American Psychiatric Association. (2022). Diagnostic and Statistical Manual of Mental Disorders (5th ed., text rev.); Sadock, B. J., Sadock, V. A., & Ruiz, P. Kaplan & Sadock's Synopsis of Psychiatry (11th ed.).

A note on this page: This content is for general education only and is not a substitute for a professional diagnosis. If any of this resonates with you, booking a consultation is the right next step.

Recognize some of this?

An initial consultation is the best way to talk through what you're experiencing.

Book an Appointment